About the Conference

12th world Congress on Precision and Personalized Medicine (PERSONALIZED MEDICINE 2022) to have a meaningful discussion with scholars during September 26-27, 2022 Singapore City, Singapore. The theme “Latest and advanced therapeutic approach of herbals towards COVID-19 pandemic''.

Conference Series LLC Ltd  invites Conference welcomes the Professors, Pathologists, Specialists, Clinical Geneticist,  Cytogenetic Diagnostics, Therapists, Researchers Specialized from Molecular Genetics and Genomics, Physicians and Hospitalists with different specialties such as Endocrinologist, Cardiologist, Nephrologist, Orthopedic, Hematologists, Immunologists, Oncologists, Rheumatologist, Research scholars, Industrial professionals and Student delegates from Biomedical, Pharmaceuticals and Telemedicine and Healthcare Sectors to be a part of it, from all over the world to Bangkok, Thailand.

Why to attend:

The Personalized medicine will enlighten the world with recent advances in personalized medicine and Novel research and inculcate new ideas about Novel health. Moreover, this personalized medicine Conferences provides the participants a great networking with peers. Internationally prominent speakers, the novel techniques, and the modern updates in the personalized medicine. Fields are the unique attributes of this conference. Personalized medicine symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about personalized medicine and Novel Therapies.

Personalized Medicine 2022 anticipates participants around the globe with thought-provoking Keynote lectures, Oral, Young Researcher Forum and Poster presentations with Exhibition. The attending delegates include Editorial Board Members of related Journals.

After Successful completion of Personalized Medicine Congress 2021, welcomes all to join the exclusive event 12th World Congress on Precision and Personalized Medicine,Singapore City, Singapore. and showcase the recent research in the tremendous field of personalized medicine among the experts

Conference theme: Latest and advanced therapeutic approach of herbals towards COVID-19 pandemic

Students are warmly welcome to attend or to present their research work as Poster Presenter and Young researcher Forum in the prestigious profile Personalized Medicine.

Personalized medicines:

Personalized medicine is a medical practice that separates patients into different groups with medical decisions, practices, interventions and products being tailored to the individual patient based on their predicted response and risk of disease.

Personalized Medicine is eluded as individualized treatment which implies the solution of particular medications and therapeutics

Sessions/Tracks

Track 01: Predictive Biomarkers and Diagnostics

In drug, a biomarker and sub-nuclear markers is the quantifiable pointer of the reality or region of some disease state. All the more overall it is anything that can be used as a marker of a particular illness state or some other physiological state of a living being Medication Symptomatic Co-Improvement.Genomics and different developments have, all things considered, Personalized Medicine Congress 2022 added to the unmistakable verification and the change of biomarkers, for example, Stratification biomarkers in modified pharmaceutical.

Track 02: Precision Pathology

The role of predictive pathology or the accurate assessment of morphology at the microscopic level. In breast cancer, this has been most useful where histologic attributes such as the classification of tubular and cribriform carcinoma dictates surgery while neoadjuvant studies suggest that patients with lobular carcinoma are not likely to benefit from chemotherapy..  Precision pathology will focus on the evolution of predictive pathology from a subjective, 'opinion-based' approach to a quantitative science. The individual components of the precise pathology platform including advanced image analysis, biomarker quantitation with mathematical modelling and the integration with fluid-based (i.e. blood, urine) analytics as drivers of next generation precise patient phenotyping.

Track 03: Drug Target Discovery and Integration

Drug Target was discovered by identifying the active ingredient from traditional remedies or by serendipitous discovery, as with penicillin. More recently, chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that had a desirable therapeutic effect in a process known as classical pharmacology. After sequencing of the human genome allowed rapid cloning and synthesis of large quantities of purified proteins, it has become common practice to use high throughput screening of large compounds libraries against isolated biological targets which are hypothesized to be disease-modifying in a process known as reverse pharmacology. Hits from these screens are then tested in cells and then in animals for efficacy. Modern drug discovery and Integration involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. 

Track 04: Precision Medicine in Cancer Diagnosis and Treatment

The goal of surgery is to remove the cancer or as much of the cancer as possible. Chemotherapy uses drugs to kill cancer cells. Radiation therapy uses high-powered energy beams, such as X-rays, to kill cancer cells. Bone marrow transplant is also known as a stem cell transplant. Your bone marrow is the material inside your bones that makes blood cells. A bone marrow transplant can use your own cells or cells from a donor. A bone marrow transplant allows your doctor to use higher doses of chemotherapy to treat your cancer. It may also be used to replace diseased bone marrow. Immunotherapy, also known as biological therapy, uses your body's immune system to fight cancer. Some types of cancer are fueled by your body's hormones. Examples include breast cancer and prostate cancer. Removing those hormones from the body or blocking their effects may cause the cancer cells to stop growing. Targeted drug treatment focuses on specific abnormalities within cancer cells that allow them to survive. 

Track 05: Preventive Medicine & Public Health Care

Preventive Medicine is sharpened by all specialists to keep their patients sound. It is also an extraordinary therapeutic distinguishing strength saw by the American Board of Medical Specialties (ABMS). The Epidemiology Division applies inquire about systems to illustrations and explanations behind prosperity and affliction in the people and to make a translation of this learning into ventures proposed to turn away disease. The division has a long history of consideration in NIH-bolstered multi-site, longitudinal accomplice studies, and its staff deal with various pro began, The result of Public health surveillance is the identification and prioritization of public health issues the world is facing today, including HIV/AIDS, antibiotic resistance, diabetes, zoonotic diseases, and waterborne diseases. Preventive Medicine and Public health incorporates the interdisciplinary approaches of epidemiology, biostatistics and health services.

Track 06: Precision Medicine: Oncology and Cardiovascular

Precision Medicine in Oncology is doled out to illuminating, instructing, and encouraging the trading of clinically pertinent data with respect to the disclosure and utilization of new Drug regimens, Molecular biomarkers, Cancer genomics, The goal of the Personalized Medicine in cardiac research is to stimulate understanding of promising new essential examination disclosures for the treatment of heart disillusionment and arrhythmias through especially formed clinical trials that display suitability and security. Cardiovascular revamping suggests the changes in estimate, shape, structure and physiology of the heart after harm to the myocardium. The mischief is regularly a direct result of extraordinary myocardial dead tissue. To depict the development in lipoprotein translation by hypothyroidism, adipocytes were prepared from control and hypothyroid rats. While LPL mix was higher in hypothyroid adipocytes, with no modification in mRNA levels, there was no extension in hormone-delicate lipase (HSL) mix

Track 07: Precision Medicine: Data Analysis and Big Data Management

Genomic medicine attempts to build individualized strategies for diagnostic or therapeutic decision-making by utilizing patients’ genomic information. Big Data analytics uncovers hidden patterns, unknown correlations, and other insights through examining large-scale various data sets. While integration and manipulation of diverse genomic data and comprehensive electronic health records (EHRs) on a Big Data infrastructure exhibit challenges, they also provide a feasible opportunity to develop an efficient and effective approach to identify clinically actionable genetic variants for individualized diagnosis and therapy. In this paper, we review the challenges of manipulating large-scale next-generation sequencing (NGS) data and diverse clinical data derived from the EHRs for genomic medicine. We introduce possible solutions for different challenges in manipulating, managing, and analyzing genomic and clinical data to implement genomic medicine.

Track 08: Precision Immunotherapy

Immunotherapy is a type of treatment that helps the body’s immune system fight cancer. Several kinds of immunotherapy, including immune checkpoint inhibitors, adoptive cell transfer, and therapeutic vaccines are either commercially available or in clinical development. To date, six immune checkpoint inhibitors have been approved by FDA for the treatment of eight types of cancer. One of the inhibitors has also been approved to treat any solid tumour that has a specific genetic feature. This was the first FDA approval of its kind and a major advance for precision cancer medicine, in which the molecular characteristics of a tumour are used to identify effective therapies.

Track 09: Advances in Precision Diagnostics

Precision medicine aims to tailor treatments based on individual characteristics, including differences in genetics, environment, and lifestyle. It has the potential to transform the delivery of care for a variety of diseases and we are already seeing the benefits of this approach in oncology. To highlight the importance of precision medicine and the key role of diagnostics in ensuring the success of President Obama's Precision Medicine Initiative, the AACR and AdvaMedDx held a congressional briefing featuring some of the top minds across the medical research spectrum, from government agencies, academia, industry, and patient advocacy.

Track 10: Proteomics and Genomics in Personalized Medicine

The proteome is the entire set of proteins it is expressed by genome, cell, tissue, or organism at a certain time. More specifically, it is a combined of proteins and genomes. Proteomics is the study of the proteome. A cellular proteome is the collection of proteins present in a particular cell type and it exposure to hormone stimulation. It can also be useful to consider an organism’s complete proteome, which can be conceptualized as the complete set of proteins from all of the various cellular proteomes. Proteome used to refer to the collection of proteins in certain sub-cellular biological systems.

Track 11: Personalized Drug Therapy in Diabetics

The definition of personalized medicine for diabetes (PMFD) is the use of information about the genetic makeup of a person with diabetes to tailor strategies for preventing, detecting, treating, or monitoring their diabetes. The practice of PMFD involves four processes. First is the identification of genes and biomarkers for diabetes as well as for obesity, which is the greatest risk factor for type 2 diabetes. Second, after these predictors of diabetes are identified, is allocation of resources to prevent or detect the diabetes and/or obesity phenotype in high-risk individuals, whose risk is based on their genotype. Third is selection of individualized therapies for affected individuals. The selection process involves deciding which drug to prescribe, what dose of drug to use, and which diet to prescribe. The selection process also accounts for which drug is least likely to cause side effects or toxicity. Fourth is measurement of circulating biomarkers of diabetes to monitor the response to prevention or  therapy.

Track 12: Personalised medicine for CNS diseases

A neurological issue is any tumour of the body sensory system. Auxiliary, biochemical or electrical variations from the norm of mind, spinal string or different nerves can bring about a scope of side effects. The indications incorporate loss of motion, muscle shortcoming, loss of sensation, seizures perplexity torment and changed levels of consciousness. They might be surveyed by neurological examination, considered and treated inside the specialities of neurology and clinical neuropsychology.

Track 13: Treatment of Genetic Disorders

Gene therapy is hoped to cure or improve treatment of genetic disorders by replacing the mutated or malfunctioned gene, manipulating or turning off the gene causing the disease or stimulate other bodily functions to fight the disease. These have the ability to identify certain cells as well as to transmit the genetic material into the cells containing malfunctioned or missed gene. For that reason modified viruses are used as vectors or carriers of the healthy genes. This method of insertion of healthy genes may not seem problematic at a first glance but it can cause potentially serious complications as already mentioned earlier.

Track 14: Stem Cells and Cell therapy

Personalized Medicine can be used to discover around a man's genetic beauty care products and to unravel the study of their tumour. Using this information, experts need to perceive reckoning, screening, and treatment procedures that may be more fruitful and cause less indication than would be ordinary with standard drugs. By performing more innate tests and examination, authorities may adjust treatment to each patient's needs. Making a tweaked harm screening and treatment game plan consolidates: Determining the chances that a man will make development and choosing screening methods to cut down the threat, Matching patients with meds that will presumably be convincing and cause less responses, Predicting the risk of rehash (return of Cancer).

Track 15: Personalized Health Care Delivery

Personalized drug is a field of prescription that includes anticipating the probability of disease and building up preventive measures remembering the true objective to either keep the infirmity all things considered or out and out reduction its impact upon the patient, (for instance, by maintaining a strategic distance from mortality or compelling grimness). Strategies and measures join New-conceived screening, diagnostic testing, Pre-birth testing: Prenatal testing is used to look for disorders and conditions in a hatchling or creating life before it is imagined.  Pre-birth testing can offer a couple some help with choosing whether to rashly end the pregnancy. Like symptomatic testing, pre-birth testing can be non-obtrusive or meddlesome. Non-prominent techniques fuse examinations of the woman's womb through ultrasonography or maternal serum screens. These non-nosy methodology

Market Analysis

Summary of Personalized Medicine 2022:

12th World Congress on Precision and Personalized Medicine contribute the opportunities to determine advance techniques used in Diagnostics labs, Genetics, Biology labs and which basically deals with the latest research and developments in the sphere of genetics and molecular biology. This Conference will provide a perfect platform to all the International mix of leading Research Scholars, and Scientists achieved eminence in their field of study, research academicians from the universities and research institutions, industrial research professionals and business associates along with PhD Students to come and inform all the attendees about the latest scientific advancements on the respective sphere.

Scope and importance:

12th World Congress on Precision and Personalized Medicine is a perfect platform for Expanding the innovative techniques and novel research trends in clinical genetics. Clinical research is a versatile conference that offers expert diagnosis, treatment all types of disorders in genetics and Drug therapies, Biological therapies. With the Annual meeting on Geneticist’s, Cytopathologists, Pathologist, Clinical research, case reports we will expect the expert gathering from Universe so that novel idea or novel research will come with a discussion at the conference and that will be fruitful to children adversity from different types of diseases. This International Personalized Medicine Conference additionally supports the dynamic cooperation of youthful understudy analysts as we are facilitating Poster Award Competition and Young research Forum at the meeting setting.

Market research:

The global personalized medicine in the market was valued at USD 1,007.88 billion in 2020 and is expected to reach USD 2,452.50 billion in 2022, growing at a CAGR of 11.8% over the forecast period. Key drivers of the market include growing development of next-generation sequencing, whole genome technology, companion diagnostics and the growing number of retail clinics. Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, the growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth. Increasing adoption of next-generation sequencing for genetic mapping of patients by clinicians and medical practitioners worldwide and growing support for personalized medicine by reimbursement and regulatory landscape are also factors expected to drive demand through to 2022. Market growth is also expected to rise through the novel introduction of drugs with associated and companion diagnostics, and growing usage of highly sensitive, accurate genetic diagnostic techniques for disease testing and risk assessment. Anticipated increase advanced DNA diagnostic usage combined with the reduction in implementation costs for whole genome sequencing is expected to considerably increase penetration rates.

Past Conference Report

Conference Series LLC LTD proudly announces the successful completion of the “11thWorld Congress on Precision and Personalized Medicine” August 14-15, 2021 Auckland, New Zealand

With the support and contribution from the esteemed Organizing Committee Members, Speakers, Delegates, Media Partners, and other supporters.

Firstly, we are thankful to you for trusting us and a part of the Personalized Medicine 2021, a global platform to discuss various important aspects of clinical research and case studies. There are infinite reasons to extend our gratitude to all our supporters for making the Personalized Medicine 2021 a great conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Personalized Medicine 2021 a new height in the field of healthcare.

The conference was manifest with the presence of global experts both from academia and industries, young and brilliant researchers, business & academic delegates and student communities from more than 25 countries, who have driven this conference into the path of success.   

Personalized Medicine congress 2021 was based on the theme “comprehensive overview of what personalized Medicine means today.” The event rooted a firm relation of upcoming strategies in the field of Pathology with the medical community and promoted many collaborated research activities. The conference witnessed an amalgamation of peerless speakers, Keynote/plenary speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of medicine & healthcare through their fabulous presentations at the platform of Personalized Medicine 2021.   

Conference Series LLC Ltd. offers its heartfelt gratitude and appreciation to all the Organizing Committee Members, Keynote Speakers, Chairs and Co-chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Pharmacogenomics & Pharmacoproteomics who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

A Special thanks to the Organizing Committee Members of Personalized Medicine 2021, Keynote Speakers, Chairs and Co-chairs without whom it might have a very difficult scenario for us to deliver the amazing conference.

So a continuation of Case Reports Conferences series, we would like to heartily welcome you to our upcoming (12th world Congress on Precision and Personalized Medicine) to seeing your benign presence with active contribution and support to make this upcoming Personalized Medicine 2022 a huge success.

Let’s meet again @ Budapest, Hungary for Personalized Medicine 2022